胸部瘤学的前沿:在分子标和免疫疗法方面取得新的突破
Yujing Yang1, Dan Pu2, Xuehan Li1
1Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in immunology
|December 31, 2025
概括
新的分子向疗法和免疫疗法策略在治疗肺癌等胸部瘤方面表现有前途,与传统方法相比,提供更好的结果和更少的副作用.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 医学治疗学 医学治疗学
背景情况:
- 胸部瘤 (肺癌,乳腺癌,胸腺瘤) 往往具有不良的预后.
- 目前用于胸部瘤的治疗方法具有有限的疗效和显著的不良影响.
- 新兴的分子向疗法和免疫疗法提供了新的治疗途径.
研究的目的:
- 审查分子向治疗和胸部瘤免疫治疗的最新进展.
- 讨论这些新型治疗策略的临床应用,挑战和潜在解决方案.
- 为改善胸部瘤患者的治疗结果提供基础,并指导未来的研究.
主要方法:
- 对针对胸部恶性瘤的向治疗和免疫治疗的最新研究进行了全面的文献综述.
- 对临床试验数据和研究结果的分析.
- 综合有关疗效,安全性和适用性的信息.
主要成果:
- 分子向疗法和免疫疗法显示出在胸部瘤中提高疗效的潜力.
- 与传统治疗相比,这些新的方法可能会降低毒性.
- 确定的挑战包括抵抗机制和最佳患者选择.
结论:
- 分子向疗法和免疫疗法代表了胸部瘤治疗中的显著范式转变.
- 需要进一步的研究来克服当前的挑战,并优化临床应用.
- 这些策略有望提高胸部瘤患者的生存率和生活质量.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


